<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>21(1)</volume><submitter>Thomas SR</submitter><pubmed_abstract>Proteolysis targeting chimeras (PROTACs) are bifunctional molecules designed to induce the degradation of specific proteins within a cell. While most PROTACs are noncovalent interactors, covalent PROTACs may benefit from improved selectivity and pharmacodynamics, yet remain largely understudied. Here, a covalent gold-based PROTAC (&lt;b>AuPROTAC&lt;/b>) was synthesized, featuring a Au(III)-warhead, known to induce cysteine-arylation in a gold-templated two-step mechanism, linked to a cereblon binding moiety. The degradome of the &lt;b>AuPROTAC&lt;/b> was characterized by establishing a cycloheximide chase assay in a nonproliferative steady-state HL-60 cell culture, enabling the identification of PROTAC degradation targets uncoupled from confounding effects originating from cell-cycle-dependent transla</pubmed_abstract><journal>ACS chemical biology</journal><pagination>170-186</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12813982</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>A Gold-PROTAC Degrades the Oncogenic Tyrosine Kinase MERTK: Insights into the Degradome from a Steady-State System.</pubmed_title><pmcid>PMC12813982</pmcid><pubmed_authors>Casini A</pubmed_authors><pubmed_authors>Gerner C</pubmed_authors><pubmed_authors>Thomas SR</pubmed_authors><pubmed_authors>Meier-Menches SM</pubmed_authors><pubmed_authors>Park M</pubmed_authors><pubmed_authors>Iellici T</pubmed_authors><pubmed_authors>Bileck A</pubmed_authors><pubmed_authors>Klaus E</pubmed_authors></additional><is_claimable>false</is_claimable><name>A Gold-PROTAC Degrades the Oncogenic Tyrosine Kinase MERTK: Insights into the Degradome from a Steady-State System.</name><description>Proteolysis targeting chimeras (PROTACs) are bifunctional molecules designed to induce the degradation of specific proteins within a cell. While most PROTACs are noncovalent interactors, covalent PROTACs may benefit from improved selectivity and pharmacodynamics, yet remain largely understudied. Here, a covalent gold-based PROTAC (&lt;b>AuPROTAC&lt;/b>) was synthesized, featuring a Au(III)-warhead, known to induce cysteine-arylation in a gold-templated two-step mechanism, linked to a cereblon binding moiety. The degradome of the &lt;b>AuPROTAC&lt;/b> was characterized by establishing a cycloheximide chase assay in a nonproliferative steady-state HL-60 cell culture, enabling the identification of PROTAC degradation targets uncoupled from confounding effects originating from cell-cycle-dependent transla</description><dates><release>2026-01-01T00:00:00Z</release><publication>2026 Jan</publication><modification>2026-07-15T13:31:34.842Z</modification><creation>2026-07-05T03:08:34.868Z</creation></dates><accession>S-EPMC12813982</accession><cross_references><pubmed>41486557</pubmed><doi>10.1021/acschembio.5c00860</doi></cross_references></HashMap>